Levetiracetam thorough QT study: Lack of proarrhythmic effect

被引：0
|
作者：
Hulhoven, Reginald [1 ]
Rosillon, D. [1 ]
Bridson, W. [2 ]
Salas, E. [3 ]
Chen, D. [3 ]
Watanabe, S. [1 ]
Meeus, M. A. [1 ]
Stockis, A. [1 ]
机构：
[1] UCB Bioprod SA, Braine lAlleud, Belgium
[2] Covance Inc, Clin Res Unit, Madison, WI USA
[3] UCB Inc, Smyma, GA USA
来源：
EPILEPSIA | 2007年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：361 / 361
页数：1
相关论文
共 50 条
  • [1] Levetiracetam thorough QT study: lack of proarrhythmic effect
    Hulhoven, R.
    Rosillon, D.
    Bridson, W.
    Salas, E.
    Chen, D.
    Watanabe, S.
    Meesus, M.
    Stockis, A.
    EPILEPSIA, 2007, 48 : 64 - 65
  • [2] Brivaracetam thorough QT study: Lack of proarrhythmic effect
    Rosillon, D.
    Astruc, B.
    Bendahmane, S.
    Hulhoven, R.
    Meeus, M. A.
    Troenaru, M.
    Watanabe, S.
    Stockis, A.
    EPILEPSIA, 2007, 48 : 329 - 329
  • [3] LACK OF EFFECT OF GABAPENTIN ENACARBIL ON CARDIAC REPOLARIZATION IN A THOROUGH QT STUDY.
    Chen, D.
    Lal, R.
    Zomorodi, K.
    Atluri, H.
    Ho, J.
    Luo, W.
    Tovera, J.
    Bonzo, D.
    Cundy, K. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S60 - S61
  • [4] LACK OF RG7128 EFFECT ON CARDIAC CONDUCTION IN A THOROUGH QT STUDY
    Haznedar, J. Oe
    Vistuer, C.
    Kulkarni, R.
    Washington, C.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S492 - S492
  • [5] Lack of significant effect of bilastine on ventricular repolarization. A thorough QT/QTc study
    Sologuren, A.
    Valiente, R.
    Allison, M.
    Tyl, B.
    ALLERGY, 2008, 63 : 85 - 85
  • [6] Pharmacokinetic/Pharmacodynamic Modeling to Support A Lack of Effect of Tafenoquine (TQ) on the QT Interval in a Thorough QT (TQT) Study
    Patel, Bela
    Miller, Ann
    Tenero, David
    Green, Justin
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S8 - S8
  • [7] Vigabatrin Lacks Proarrhythmic Potential: Results from a Thorough QT/QTc Study in Healthy Volunteers
    Tolbert, Dwain
    Reid, Susan
    Harris, Stuart
    Bekersky, Ihor
    CLINICAL THERAPEUTICS, 2017, 39 (08) : 1639 - 1648
  • [8] A Quantitative Framework to Evaluate Proarrhythmic Risk in a First-in-Human Study to Support Waiver of a Thorough QT Study
    Nelson, C. H.
    Wang, L.
    Fang, L.
    Weng, W.
    Cheng, F.
    Hepner, M.
    Lin, J.
    Garnett, C.
    Ramanathan, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (06) : 630 - 638
  • [9] Thorough QT study of the effect of fesoterodine on cardiac repolarization
    Malhotra, B.
    Wood, N.
    Sachse, R.
    Gandelman, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (05) : 309 - 318
  • [10] A thorough QT study of guanfacine
    Martin, Patrick
    Satin, Lawrence
    Kahn, Robert S.
    Robinson, Antoine
    Corcoran, Mary
    Purkayastha, Jaideep
    Youcha, Sharon
    Ermer, James C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (04) : 301 - 316
12345